MedTrace Logo

Testing an AI Tool to Help Primary Care Clinicians With Specialty Consultation Questions

NCT07706920 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-07-16

No results posted yet for this study

Summary

The goal of this study is to test an artificial intelligence (AI) tool called SAGE. SAGE helps primary care doctors with questions that often need a specialist. Primary care doctors are the doctors people usually see first. SAGE reviews a case and suggests what a specialist might advise.

The main questions it aims to answer are:

* Do doctors make sound, timely care decisions when they use SAGE?
* Do those decisions match what a specialist would advise?

Researchers will compare the decisions doctors make with and without SAGE.

Doctors in the study will:

* Review made-up patient cases (these are not real patients)
* Make a decision for each case, their usual way and with SAGE

Conditions

  • Decision Support Systems, Clinical
  • Referral and Consultation

Interventions

OTHER

SAGE (AI clinical decision support)

SAGE is an artificial intelligence (AI) based clinical decision support tool. It generates specialty-informed recommendations for a primary care consultation question. Physicians review the SAGE output while making a management decision for the synthetic case.

OTHER

Standard eConsult

A standard electronic consultation (eConsult) format, without SAGE. Physicians review this information while making a management decision for the synthetic case.

Sponsors & Collaborators

Principal Investigators

  • Jonathan Chen, MD, PhD · Stanford University

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07706920 on ClinicalTrials.gov